About the Authors
- Lotta Walz
-
* E-mail: Lotta.walz@ki.se
Affiliations Forensic Medicine Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, MSD AB, Stockholm, Sweden
- Anna K. Jönsson
-
Affiliation Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden
- Brita Zilg
-
Affiliations Forensic Medicine Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Department of Forensic Medicine, National Board of Forensic Medicine, Stockholm, Sweden
- Carl Johan Östgren
-
Affiliation Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
- Henrik Druid
-
Affiliation Forensic Medicine Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Competing Interests
Carl Johan Östgren has participated in clinical drug trials, advisory boards, and has given lectures for Astra Zenca, NovoNordisk and MSD in the areas of diabetes, hypertension and dyslipidemia. The author, Walz has a competing interest to declare as an employee at MSD and may own stocks or have stock options in the company. Anna K.Jönsson, Henrik Druid and Brita Zilg have no conflict of interest to declare in this work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: LW HD AJ. Data curation: LW HD AJ. Formal analysis: LW HD AJ BZ. Funding acquisition: HD CJÖ. Investigation: LW HD AJ BZ. Methodology: LW HD AJ BZ. Project administration: LW HD AJ. Resources: LW HD AJ BZ. Supervision: HD AJ CJÖ. Validation: LW HD BZ. Visualization: LW AJ. Writing – original draft: LW. Writing – review & editing: LW HD AJ BZ CJÖ.